semaglutide blindness study A new suggests patients taking — the active ingredient in Ozempic and Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Ozempic Blindness In 2025: Essential

Proper nutrition combined with targeted supplementation creates a foundation that supports both effective weight loss and long-term health preservation

For weight loss specifically, breastfeeding itself increases caloric expenditure by 300500 calories daily, meaning many mothers see natural weight reduction over the first 612 months postpartum without pharmaceutical intervention

Brand, K

John Diaz, described as a board-certified plastic surgeon Service model: brand-stated physician-reviewed telehealth treatment plans across weight loss, longevity, and hair Primary weight-loss medications: compounded semaglutide and compounded tirzepatide (injectable and capsule forms) Brand-name GLP-1 options referenced: Ozempic, Wegovy, Zepbound Compounded semaglutide injection: brand-stated $249 first month Compounded tirzepatide injection: brand-stated $329 first month Compounded semaglutide capsules / tirzepatide capsules: brand-stated $249 / $349 first month Plan tiers (weight loss): brand-stated $249 monthly, $219/mo three-month, $199/mo six-month, $194/mo twelve-month What the price includes (brand-stated): consultation, medication, supplies, shipping, and support Administration: weekly self-administered subcutaneous injection (for injectable GLP-1) Cancellation (brand-stated): cancel or change plans anytime - confirm the method and timing before enrolling Eligibility: adults 18 and older (per Terms of Service) Prescription: determined by a licensed provider